These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 22639401

  • 1. Sirolimus: more cause for alarm?
    Agarwal PD, Lucey MR.
    Liver Transpl; 2012 Sep; 18(9):1003-4. PubMed ID: 22639401
    [No Abstract] [Full Text] [Related]

  • 2. End of the line for sirolimus in liver transplant recipients with hepatitis C virus?
    De Simone P, Saliba F, Fischer L.
    Liver Transpl; 2013 Feb; 19(2):236-7. PubMed ID: 23225519
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sirolimus and mTOR inhibitors in liver transplantation: the wheel has come full circle.
    Levitsky J, Feng S.
    Am J Transplant; 2014 Feb; 14(2):249-50. PubMed ID: 24620373
    [No Abstract] [Full Text] [Related]

  • 5. Influence of immunosuppression on patient survival after liver transplantation for hepatitis C.
    Mueller AR, Platz K, Willimski C, Berg T, Steinmüller T, Neumann U, Neuhaus R, Hopf U, Radke C, Neuhaus P.
    Transplant Proc; 2001 Feb; 33(1-2):1347-9. PubMed ID: 11267321
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation.
    Langrehr JM, Lohmann R, Guckelberger O, Müller AR, Raakow R, Nüssler NC, Klupp J, Pfitzmann R, Jonas S, Settmacher U, Steinmüller T, Neuhaus P.
    Transplant Proc; 2001 Feb; 33(1-2):1433-4. PubMed ID: 11267360
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results.
    Pridöhl O, Heinemann K, Hartwig T, Witzigmann H, Lamesch P, Fangmann J, Berr F, Hauss J, Kohlhaw K.
    Transplant Proc; 2001 Feb; 33(7-8):3229-31. PubMed ID: 11750384
    [No Abstract] [Full Text] [Related]

  • 12. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO, Neuhaus P, McMaster P, Calne R, Pichlmayr R, Otto G, Williams R, Ericzon BG, Bismuth H.
    Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Liver transplantation using sirolimus and minimal corticosteroids (3-day taper).
    Trotter JF, Wachs M, Bak T, Trouillot T, Stolpman N, Everson GT, Kam I.
    Liver Transpl; 2001 Apr; 7(4):343-51. PubMed ID: 11303295
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation.
    Lauro A, Dazzi A, Ercolani G, Zanfi C, Golfieri L, Amaduzzi A, Cucchetti A, La Barba G, Grazi GL, D'Errico A, Vivarelli M, Cescon M, Varotti G, Del Gaudio M, Ravaioli M, Di Simone M, Faenza S, Pironi L, Pinna AD.
    Transplant Proc; 2007 Jun; 39(5):1629-31. PubMed ID: 17580204
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.